{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:40:34Z","timestamp":1789612834095,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajpc.2025.100999","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T06:33:54Z","timestamp":1745044434000},"page":"100999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chronic statin-use before PCI in acute coronary syndromes and in-hospital outcomes: ACC NCDR registry in India"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-3137","authenticated-orcid":false,"given":"Rajeev","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender S","family":"Makkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kasliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu","family":"Natani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghubir S","family":"Khedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soneil","family":"Guptha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.100999_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidemia: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0002","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA \/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.100999_bib0003","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0004","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.100999_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5334\/gh.1154","article-title":"World Heart Federation cholesterol roadmap 2022","volume":"17","author":"Ray","year":"2022","journal-title":"Glob Heart"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2025.100999_bib0006","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ihj.2023.11.271","article-title":"CSI clinical practice guidelines for dyslipidemia management: executive summary","volume":"76","author":"Sawhney","year":"2024","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0007","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(19)31893-8","article-title":"Primary prevention of ischemic heart disease: populations, individuals and healthcare professionals","volume":"394","author":"Gupta","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.100999_bib0008","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1002\/clc.22169","article-title":"Effect of statin pretreatment on myocardial perfusion in patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis","volume":"36","author":"Lyu","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0009","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.clinthera.2006.11.003","article-title":"Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous intervention","volume":"28","author":"Ishii","year":"2006","journal-title":"Clin Therap"},{"key":"10.1016\/j.ajpc.2025.100999_bib0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4070\/kcj.2011.41.8.458","article-title":"Effect of previous statin therapy in patients with acute coronary syndrome and percutaneous coronary intervention","volume":"41","author":"Yun","year":"2011","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijcard.2012.01.009","article-title":"The prognostic value of very low admission LDL cholesterol levels in ST-segment elevation myocardial infarction compared to statin-pretreated and statin-na\u00efve patients undergoing primary percutaneous coronary intervention","volume":"167","author":"Oduncu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0012","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2016.02.088","article-title":"Association between statin treatment and LDL cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACVSIS) 2002-2010","volume":"210","author":"Gottlieb","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0013","doi-asserted-by":"crossref","first-page":"afac121","DOI":"10.1093\/ageing\/afac121","article-title":"Association of statin pretreatment with presentation characteristics, infarct size and outcome in older patients with acute coronary syndrome: the elderly ACS-2 Trial","volume":"51","author":"Toso","year":"2022","journal-title":"Age Aging"},{"key":"10.1016\/j.ajpc.2025.100999_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ihj.2023.01.004","article-title":"Prior statin use and the incidence of in-hospital arrhythmia in acute coronary syndrome: a systematic review and meta-analysis","volume":"75","author":"Wibawa","year":"2023","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/FJC.0000000000001345","article-title":"Extent of low-density lipoprotein cholesterol reduction and all-cause and cardiovascular mortality benefit: a systematic review and meta-analysis","volume":"81","author":"Ennezat","year":"2023","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","article-title":"Repositioning of the global epicentre of non-optimal cholesterol","volume":"582","year":"2020","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2025.100999_bib0017","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ihj.2023.11.266","article-title":"Trends in epidemiology of dyslipidemias in India","volume":"76","author":"Sharma","year":"2024","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0018","article-title":"Association of health insurance status with cardiovascular risk factors, coronary artery disease, coronary interventions, and outcomes in India","volume":"14","author":"Gupta","year":"2022","journal-title":"Int J Cardiol: Cardiovasc Risk Prev"},{"key":"10.1016\/j.ajpc.2025.100999_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ihj.2022.08.003","article-title":"Premature coronary artery disease, risk factors, coronary angiography and interventions: a hospital-based registry in India","volume":"74","author":"Sharma","year":"2022","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102709","article-title":"Association of diabetes with coronary artery disease, risk factors, clinical presentation, angiography, interventions, and outcomes: a prospective registry in India","volume":"17","author":"Gupta","year":"2023","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"key":"10.1016\/j.ajpc.2025.100999_bib0021","article-title":"Low body mass index is associated with adverse cardiovascular outcomes following PCI in India: ACC-NCDR Registry","volume":"20","author":"Gupta","year":"2024","journal-title":"Int J Cardiol: Cardiovasc Risk Prev"},{"key":"10.1016\/j.ajpc.2025.100999_bib0022","article-title":"Influence of Covid-19 pandemic in India on coronary artery disease clinical presentations, angiography, interventions, and outcomes: a single centre prospective registry","volume":"15","author":"Gupta","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajpc.2025.100999_bib0023","unstructured":"American College of Cardiology\u2019s CathPCI registry. Available at: https:\/\/cvquality.acc.org\/NCDR-Home\/registries\/hospital-registries\/cathpci-registry. Accessed 30 April 2023."},{"key":"10.1016\/j.ajpc.2025.100999_bib0024","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/eurheartj\/ehac249","article-title":"Cardiovascular disease, mortality and their associations with modifiable risk factors in a multinational South Asia cohort: a PURE substudy","volume":"43","author":"Joseph","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0026","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.100999_bib0027","series-title":"The esc textbook of cardiovascular medicine","first-page":"1255","article-title":"Treatment of ST-elevation acute coronary syndromes","author":"Ibanez","year":"2019"},{"key":"10.1016\/j.ajpc.2025.100999_bib0028","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic and clinical studies. A consensus statement from the European Atherosclerotic Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0029","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2025.100999_bib0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018897","article-title":"Lipid management in patients presenting with acute coronary syndromes: a review","volume":"9","author":"Claessen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.100999_bib0031","first-page":"H1960","article-title":"Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cycloxygenase-2","volume":"290","author":"Atar","year":"2006","journal-title":"Am J Physiol: Circ Physiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0032","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.00962.2004","article-title":"Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion","volume":"288","author":"Weinberg","year":"2005","journal-title":"Am J Physiol Circ Physiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0033","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/joic.12421","article-title":"Pre-loading therapy with statins in patients with angina and acute coronary syndromes undergoing PCI","volume":"30","author":"Lampropoulos","year":"2017","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0034","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"for PROVE-IT TIMI 22 (Pravastatin or atorvastatin evaluation and infarction therapy-Thrombolysis in myocardial infarction-22) investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.100999_bib0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.CIR.0000137828.06205.87","article-title":"Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) study","volume":"110","author":"Pasceri","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.100999_bib0036","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jacc.2007.02.025","article-title":"Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial","volume":"49","author":"Patti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0037","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcin.2009.11.021","article-title":"Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST segment elevation myocardial infarction: the STATIN STEMI trial","volume":"3","author":"Kim","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ajpc.2025.100999_bib0038","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ccd.23449","article-title":"Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomised placebo-controlled pilot trial","volume":"80","author":"Post","year":"2012","journal-title":"Cath Cardiovasc Interv"},{"key":"10.1016\/j.ajpc.2025.100999_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2014.03.059","article-title":"Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study)","volume":"114","author":"Ko","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0040","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.110.002451","article-title":"Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomised studies","volume":"123","author":"Patti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.100999_bib0041","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12944-020-01369-6","article-title":"High-intensity statin therapy yields better outcomes in acute coronary syndrome patients: a meta-analysis involving 26,497 patients","volume":"19","author":"Yu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ajpc.2025.100999_bib0042","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.3390\/jcm11185298","article-title":"Impact of prior statin therapy on in-hospital outcome of STEMI patients treated with primary percutaneous coronary intervention","volume":"11","author":"Lanza","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpc.2025.100999_bib0043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ihj.2020.03.015","article-title":"Rationale for aggressive use of statins for primary prevention of atherosclerotic cardiovascular disease in Indians","volume":"72","author":"Enas","year":"2020","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ajpc.2025.100999_bib0044","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jacc.2024.10.121","article-title":"Secondary prevention medications in 17 countries grouped by income level (PURE): a prospective cohort study","volume":"85","author":"Joseph","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.100999_bib0045","article-title":"Escalating ischemic heart disease burden among women in India: insights from GBD, NCDRisC and NFHS reports","volume":"2","author":"Gaur","year":"2020","journal-title":"Am J Prev Cardiol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T15:37:05Z","timestamp":1751989025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":45,"alternative-id":["S2666667725000741"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.100999","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic statin-use before PCI in acute coronary syndromes and in-hospital outcomes: ACCNCDR registry in India","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.100999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100999"}}